Bone Densitometers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report View Sample

Published: November 13, 2023 Report Code: GDME1638EPD-ST

Select Item

Bone Densitometers Pipeline Market Report Overview

Bone densitometers are devices used to measure bone mineral density with techniques such as Dual-Energy X-ray Absorptiometry (DEXA), Quantitative Computed Tomography (QCT), Radiographic Absorptiometry (RA), and Quantitative Ultrasound (QUS). Dual Energy X-ray Absorptiometry (DEXA) and Quantitative Ultrasound (QUS) are tracked under this category.

The bone densitometers pipeline market research report provides comprehensive information about the bone densitometers pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·        Dual Energy X-Ray Absorptiometry (DEXA)

·        Quantitative Ultrasound (QUS)
Key Territories ·        Global

·        The US

·        Europe
Key Regulatory Paths ·        510(k)

·        CE
Leading Companies ·        3D Osteo Limited

·        ARTANN Laboratories Inc

·        BrainLAB AG

·        Clemson University

·        Columbia University
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Bone Densitometers Pipeline Market by Segments

The key segments in the bone densitometers pipeline market are Dual Energy X-Ray Absorptiometry (DEXA) and Quantitative Ultrasound (QUS). As of November 2023, Dual Energy X-Ray Absorptiometry (DEXA) has the most pipeline products.

Bone Densitometers Pipeline Market Analysis by Segments, 2023 (%)

Bone Densitometers Pipeline Market Analysis by Segments, 2023 (%)

Buy Full Report for More Segment Insights into the Bone Densitometers Pipeline Market

Download a Free Report Sample

Bone Densitometers Pipeline Market Segmentation by Territories

Some of the key territories in the bone densitometers market are the US, Global, and Europe. As of November 2023, the global segment has the highest number of pipeline products.

Bone Densitometers Pipeline Market Analysis by Territories, 2023 (%)

Bone Densitometers Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Bone Densitometers Pipeline Market

Download a Free Report Sample

Bone Densitometers Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the bone densitometers pipeline market are 510(k) and CE. As of November 2023, 510(k) is the most followed pathway for pipeline products in the market.

Bone Densitometers Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Bone Densitometers Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Bone Densitometers Pipeline Market

Download a Free Report Sample

Bone Densitometers Pipeline Market – Competitive Landscape

Some of the key companies in the bone densitometers pipeline market are:

  • 3D Osteo Limited
  • ARTANN Laboratories Inc
  • BrainLAB AG
  • Clemson University
  • Columbia University

ARTANN Laboratories Inc: It operates as a medical device company that provides ultrasound solutions. The company offers early-stage development and validation of original technologies and devices. Its products include tissue elastometers and breast models. Artann’s products provide processing of technologies such as mechanical imaging, breast mechanical imaging, bone ultrasonometry, colonoscopy force monitor, vaginal tactile imager, and others. Artann offers shear wave elasticity imaging, temperature profile spectroscopy, droplet, prostate mechanical imaging, body hydration monitor, and time reversal acoustics. Its products are used in medical, aerospace, and military applications. The company’s MI devices are used for prostate, breast, vagina and muscle abnormalities imaging. Artann is headquartered in West Trenton, New Jersey, the US.

Bone Densitometers Pipeline Market Analysis by Companies, 2023

Bone Densitometers Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Bone Densitometers Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Bone Densitometers Pipeline Market Segments Outlook

  • Dual Energy X-Ray Absorptiometry (DEXA)
  • Quantitative Ultrasound (QUS)

Bone Densitometers Pipeline Market Territories Outlook

  • The US
  • Global
  • Europe

Bone Densitometers Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE

Scope

This report provides:

  • Extensive coverage of the Bone Densitometers under development.

  • Review details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in pipeline product development and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of Bone densitometers under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

3D Osteo Limited
ARTANN Laboratories Inc
BrainLAB AG
Clemson University
Columbia University
CyberLogic Inc
Erasmus MC
Hologic Inc
IF LLC
Imperial College London
Integra LifeSciences Holdings Corp
JointVue, LLC
Quantum Medical Metrics, LLC
Sheffield Hallam University
SpineGuard SA
Surgix Ltd.
University of Brunei Darussalam
University of California San Diego

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables

    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Bone Densitometers Overview

  • 3 Products under Development

    • 3.1 Bone Densitometers – Pipeline Products by Stage of Development

    • 3.2 Bone Densitometers – Pipeline Products by Segment

    • 3.3 Bone Densitometers – Pipeline Products by Territory

    • 3.4 Bone Densitometers – Pipeline Products by Regulatory Path

    • 3.5 Bone Densitometers – Pipeline Products by Estimated Approval Date

  • 4 Bone Densitometers – Pipeline Products under Development by Companies

    • 4.1 Bone Densitometers Companies – Pipeline Products by Stage of Development

    • 4.2 Bone Densitometers – Pipeline Products by Stage of Development

  • 5 Bone Densitometers Companies and Product Overview

    • 5.1 3D Osteo Limited Company Overview

      • 5.1.1 3D Osteo Limited Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 ARTANN Laboratories Inc Company Overview

      • 5.2.1 ARTANN Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 BrainLAB AG Company Overview

      • 5.3.1 BrainLAB AG Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Clemson University Company Overview

      • 5.4.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Columbia University Company Overview

      • 5.5.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 CyberLogic Inc Company Overview

      • 5.6.1 CyberLogic Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Erasmus MC Company Overview

      • 5.7.1 Erasmus MC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Hologic Inc Company Overview

      • 5.8.1 Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 IF LLC Company Overview

      • 5.9.1 IF LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Imperial College London Company Overview

      • 5.10.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Integra LifeSciences Holdings Corp Company Overview

      • 5.11.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 JointVue, LLC Company Overview

      • 5.12.1 JointVue, LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Quantum Medical Metrics, LLC Company Overview

      • 5.13.1 Quantum Medical Metrics, LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 Sheffield Hallam University Company Overview

      • 5.14.1 Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 SpineGuard SA Company Overview

      • 5.15.1 SpineGuard SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 Surgix Ltd. Company Overview

      • 5.16.1 Surgix Ltd. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 University of Brunei Darussalam Company Overview

      • 5.17.1 University of Brunei Darussalam Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 University of California San Diego Company Overview

      • 5.18.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Bone Densitometers- Recent Developments

    • 6.1 Oct 11, 2023: SpineGuard Announces its Q3 2023 Revenue

    • 6.2 Sep 12, 2023: SpineGuard Reports Six-Month 2023 Financial Results

    • 6.3 Jun 14, 2023: SpineGuard Announces Second Call of the Annual Shareholders’ Meeting on June 29, 2023

    • 6.4 May 09, 2023: GE HealthCare Names James Saccaro Vice President and Chief Financial Officer

    • 6.5 Apr 28, 2023: United Imaging Healthcare delivers its first annual report since going public, with revenue growth of nearly 30% in 2022

    • 6.6 Apr 28, 2023: Siemens to announce second quarter results FY 2023

    • 6.7 Apr 20, 2023: DMS Group announces record quarterly revenue: €10.1 million in the 1st quarter of 2023, organic growth +16%

    • 6.8 Apr 13, 2023: SpineGuard Announces Its Full-year 2022 Financial Results and Its First Quarter 2023 Sales

    • 6.9 Mar 07, 2023: New study demonstrates that running does not increase risk of arthritis

    • 6.10 Feb 14, 2023: Siemens Limited announces Q1 FY 2023 results; 80% increase in PAT from continuing operations

    • 6.11 Feb 08, 2023: Siemens Announces Earnings Release and Financial Results for the First Quarter of Fiscal Year 2023

    • 6.12 Feb 08, 2023: United Imaging announces multiple partnerships in the Middle East and Africa at Arab Health 2023

    • 6.13 Feb 08, 2023: Siemens Announces Earnings Release Q1 FY 2023

    • 6.14 Jan 30, 2023: GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results

    • 6.15 Jan 17, 2023: GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023

    • 6.16 Jan 10, 2023: GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook

    • 6.17 Jan 09, 2023: SpineGuard Reports a +37% Increase in Q4 2022 Revenue

    • 6.18 Jan 08, 2023: Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2023

    • 6.19 Nov 21, 2022: Medimaps Group at RSNA 2022: Providing the Full Bone-Health Picture

    • 6.20 Nov 17, 2022: Siemens reports outstanding performance in fiscal 2022

    • 6.21 Nov 16, 2022: Supervisory Board renews the term of office of Judith Wiese, Managing Board Member and Chief People & Sustainability Officer

    • 6.22 Oct 31, 2022: Siemens appoints Hakan Ozdemir as CEO in Qatar

  • 7 Appendix

    • 7.1 Methodology

    • 7.2 About GlobalData

    • 7.3 Contact Us

    • 7.4 Disclaimer

Table

Bone Densitometers – Pipeline Products by Stage of Development 9_x000D_

Bone Densitometers – Pipeline Products by Segment 10_x000D_

Bone Densitometers – Pipeline Products by Territory 11_x000D_

Bone Densitometers – Pipeline Products by Regulatory Path 12_x000D_

Bone Densitometers – Pipeline Products by Estimated Approval Date 13_x000D_

Bone Densitometers Companies – Pipeline Products by Stage of Development 14_x000D_

Bone Densitometers – Pipeline Products by Stage of Development 15_x000D_

3D Osteo Limited Pipeline Products & Ongoing Clinical Trials Overview 16_x000D_

ACIST Device – Osteoporosis – Product Status 16_x000D_

ACIST Device – Osteoporosis – Product Description 16_x000D_

ARTANN Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 17_x000D_

Bone UltraSonic Scanner – Product Status 17_x000D_

Bone UltraSonic Scanner – Product Description 17_x000D_

BrainLAB AG Pipeline Products & Ongoing Clinical Trials Overview 18_x000D_

Next Generation Knee Navigation System – Product Status 18_x000D_

Next Generation Knee Navigation System – Product Description 18_x000D_

Clemson University Pipeline Products & Ongoing Clinical Trials Overview 19_x000D_

Rotator Cuff Disease Diagnosis Device – Product Status 19_x000D_

Rotator Cuff Disease Diagnosis Device – Product Description 19_x000D_

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 20_x000D_

Computed Tomography System – Osteoarthritis – Product Status 20_x000D_

Computed Tomography System – Osteoarthritis – Product Description 20_x000D_

CyberLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 21_x000D_

QRT 250 Heel Scanner – Product Status 21_x000D_

QRT 250 Heel Scanner – Product Description 21_x000D_

Erasmus MC Pipeline Products & Ongoing Clinical Trials Overview 22_x000D_

Lumbar Ultrasound Localizer – Product Status 22_x000D_

Lumbar Ultrasound Localizer – Product Description 22_x000D_

Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview 23_x000D_

Access DXA – Product Status 23_x000D_

Access DXA – Product Description 23_x000D_

IF LLC Pipeline Products & Ongoing Clinical Trials Overview 24_x000D_

PAQUS Bone Assessment Device – Product Status 24_x000D_

PAQUS Bone Assessment Device – Product Description 24_x000D_

Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 25_x000D_

Mini Magic MRI Scanner – Product Status 25_x000D_

Mini Magic MRI Scanner – Product Description 25_x000D_

Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 26_x000D_

IMWD Single – Product Status 26_x000D_

IMWD Single – Product Description 26_x000D_

JointVue, LLC Pipeline Products & Ongoing Clinical Trials Overview 27_x000D_

Vision-D Plus – Product Status 27_x000D_

Vision-D Plus – Product Description 27_x000D_

Quantum Medical Metrics, LLC Pipeline Products & Ongoing Clinical Trials Overview 28_x000D_

Multiple-Projection DXA Scanner – Product Status 28_x000D_

Multiple-Projection DXA Scanner – Product Description 28_x000D_

Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview 29_x000D_

Bone Mineral Density Assessment System – Product Status 29_x000D_

Bone Mineral Density Assessment System – Product Description 29_x000D_

SpineGuard SA Pipeline Products & Ongoing Clinical Trials Overview 30_x000D_

DSG – Bone Quality Measurement – Product Status 30_x000D_

DSG – Bone Quality Measurement – Product Description 30_x000D_

Surgix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31_x000D_

Imaging Based System – Orthopedic Trauma – Product Status 31_x000D_

Imaging Based System – Orthopedic Trauma – Product Description 31_x000D_

University of Brunei Darussalam Pipeline Products & Ongoing Clinical Trials Overview 32_x000D_

Real-time Visualization System – Product Status 32_x000D_

Real-time Visualization System – Product Description 32_x000D_

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 33_x000D_

Cartilage Compression Device – Product Status 33_x000D_

Cartilage Compression Device – Product Description 33_x000D_

Glossary 60_x000D_

Figures

Bone Densitometers – Pipeline Products by Stage of Development 8_x000D_

Bone Densitometers – Pipeline Products by Segment 9_x000D_

Bone Densitometers – Pipeline Products by Territory 10_x000D_

Bone Densitometers – Pipeline Products by Regulatory Path 11_x000D_

Bone Densitometers – Pipeline Products by Estimated Approval Date 12_x000D_

Frequently asked questions

Bone Densitometers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Bone Densitometers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Bone Densitometers reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Polymerase Chain Reaction (PCR) Systems Market Size by Segments, Share,…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Bone Densitometers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Bone Densitometers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more